5-PAHSA
5-(palmitoyloxy)octadecanoic acid
PAHSA levels correlate highly with insulin sensitivity and are reduced in adipose tissue and serum of insulin-resistant humans. In adipocytes, PAHSAs signal through GPR120 to enhance insulin-stimulated glucose uptake. Thus, FAHFAs are endogenous lipids with the potential to treat type 2 diabetes.
Avanti has obtained a license from the patent holder to manufacture these products for research use.